DOSE-ESCALATION AND PHARMACOKINETICS (PK) OF DIFFERENT LENALIDOMIDE (LEN) STARTING DOSE REGIMENS IN PATIENTS WITH RELAPSED OR REFRACTORY (REL/REF) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) (CC-5013-CLL-009) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Wendtner, C
  • Hallek, M
  • Fraser, Graeme
  • Michallet, A
  • Hillmen, P
  • Duerig, J
  • Gregory, S
  • Kalaycio, M
  • Aurran-Schleinitz, T
  • Trentin, L
  • Stilgenbauer, S
  • Kipps, T
  • Purse, B
  • Zhang, J
  • Chen, N
  • Mei, J
  • Chanan-Khan, A

publication date

  • June 12, 2013